VRAYLAR

Abbvie Corporation🇨🇦 Health Canada

Approval Id: a25a3492b3ecca6c
Drug Approval Canada Name: VRAYLAR
Product Name: VRAYLAR
Status: Marketed
Status Date: 2024-05-14
Original Market Date: 2022-06-24
Din: 02526808
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.08.04
Atc Original: N05AX15 CARIPRAZINE
Atc Name: n 05 ax 15
Aig Number: 0163581001
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

CARIPRAZINE (CARIPRAZINE HYDROCHLORIDE)

3 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a25a3492b3ecca6c

Type

Standard